1. Home
  2. >Research
  3. >Influence Of Bmi Associated Genetic Variants And Metabolic Risk Factors On Weight Loss With Semaglutide A Longitudinal Clinico Genomic Cohort Study
Skip to main content
Research

Influence of BMI-associated genetic variants and metabolic risk factors on weight loss with semaglutide: a longitudinal clinico-genomic cohort study

November 3, 2024Published Research

Ready to see the whole picture?

Connect with our team to discover how Helix can transform your approach to genomic medicine.

Connect with us
Influence of BMI-associated genetic variants and metabolic risk factors on weight loss with semaglutide: a longitudinal clinico-genomic cohort study | Helix